CaMKII inhibitor KN‐93 impaired angiogenesis and aggravated cardiac remodelling and heart failure via inhibiting NOX2/mtROS/p‐VEGFR2 and STAT3 pathways-Reference-Cited by-同舟云学术

CaMKII inhibitor KN‐93 impaired angiogenesis and aggravated cardiac remodelling and heart failure via inhibiting NOX2/mtROS/p‐VEGFR2 and STAT3 pathways

Published:2021-11-29 Issue:2 Volume:26 Page:312-325
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Ni Yajuan¹^ORCID,Deng Jie¹,Bai Hongyuan¹,Liu Chang¹,Liu Xin¹,Wang Xiaofang¹

Affiliation:

1. Department of Cardiology The Second Affiliated Hospital of Xi’an Jiaotong University Xi'an China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17081

Reference44 articles.

1. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

2. Advances in the Epidemiology of Heart Failure and Left Ventricular Remodeling

3. Calcium/Calmodulin-Dependent Protein Kinase II Activity Persists During Chronic β-Adrenoceptor Blockade in Experimental and Human Heart Failure

4. Calmodulin-Dependent Protein Kinase II: Linking Heart Failure and Arrhythmias

5. Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin‐dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy;Beauverger P;Cardiovasc Res,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of newer generation Vascular endothelial growth factor Receptor-2 Inhibitors: Pharmacophore based design, virtual Screening, molecular Docking, molecular dynamic Simulation, and DFT analyses;Journal of King Saud University - Science;2024-09

2. Discovery of FO-4-15, a novel 1,2,4-oxadiazole derivative, ameliorates cognitive impairments in 3×Tg mice by activating the mGluR1/CaMKIIα pathway;Acta Pharmacologica Sinica;2024-08-16

3. CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies;Drug Design, Development and Therapy;2024-08

4. Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2;European Journal of Pharmacology;2024-05

5. Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review);Molecular Medicine Reports;2024-03-11